Commitments and Contingencies (Details) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
|
Sep. 05, 2025
USD ($)
INSTALLMENT
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
|
|
| Commitments and Contingencies [Abstract] | |||
| Employer's matching contribution | $ 128 | $ 88 | |
| Contractual exit fees and product repurchase obligations | $ 246 | ||
| Koronis Biomedical Corporation [Member] | |||
| Commitments and Contingencies [Abstract] | |||
| Amount of grant approval received | $ 3,000 | ||
| Non-refundable technology license fee | $ 600 | ||
| Number of monthly installments (in INSTALLMENT) | INSTALLMENT | 18 | ||
| X | ||||||||||
- Definition Amount of grant approval received from National Institutes of Health to support project. No definition available.
|
| X | ||||||||||
- Definition The amount of contractual exit fees and product repurchase obligations with certain of its former international distributors. No definition available.
|
| X | ||||||||||
- Definition Amount payable as non-refundable technology license fee in collaboration agreement. No definition available.
|
| X | ||||||||||
- Definition The number of installment payments to be paid monthly over time related to a lease agreement. No definition available.
|
| X | ||||||||||
- Definition Amount of discretionary contributions made by an employer to a defined contribution plan. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|